SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-21-007764
Filing Date
2021-02-09
Accepted
2021-02-09 16:46:37
Documents
1
Group Members
YI SHI

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea134880-sc13glav_inhibrx.htm SC 13G 76456
  Complete submission text file 0001213900-21-007764.txt   78050
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Subject) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91647 | Film No.: 21607197
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address UNIT 902-904, TWO CHINACHEM CENTRAL 26 DES VOEUX ROAD CENTRAL HONG KONG K3 00000
Business Address UNIT 902-904, TWO CHINACHEM CENTRAL 26 DES VOEUX ROAD CENTRAL HONG KONG K3 00000 852-6606-2381
LAV Summit Ltd (Filed by) CIK: 0001844779 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13G